Did Debbie Schultz buy Angiodynamics stock?

Common questions

Did Debbie Schultz buy Angiodynamics stock?

Yes. Debbie Schultz disclosed 3 purchases and 3 sales of Angiodynamics (ANGO) stock between Apr 27, 2016 and Oct 20, 2025, in STOCK Act reports. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $4K-$32K.

How big were Debbie Schultz's Angiodynamics trades?

STOCK Act reports give a range for each trade, such as $2K-$2K, never an exact amount. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $4K-$32K.

Did Debbie Schultz make these Angiodynamics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Debbie Schultz still own Angiodynamics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Debbie Schultz report these trades?

The latest filing is dated Oct 24, 2025. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.